B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Fibroblast Growth Factor 2

299 PubMed studies analyzed · 2 RCTs · Evidence Score: 44.5

Research Domains

Fibroblast Growth Factor 2 has been studied across 23 research domains including 🔬 Oncology, 🦴 Bone & Joint, ✨ Skin & Hair, 🔬 Inflammation, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 15% of studies addressing this area.

Loading evidence profile...

This evidence profile for Fibroblast Growth Factor 2 is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.